U-Systems, Inc. announces technology licensing agreement with Siemens Healthcare

San Jose, Calif. – December 22, 2008 – U-Systems, Inc., the
innovative leader in dedicated breast ultrasound systems, today
announced a technology licensing agreement with the Ultrasound
Business Unit of Siemens Medical Solutions USA, Inc., Mountain
View, California. The U-Systems’ somo•VIEWer™* advanced
workstation for Automated Breast Ultrasound has been licensed
for use with Siemens’ ACUSON S2000 Automated Breast Volume
Scanner (ABVS)** recently introduced at RSNA 2008. This will allow
physicians to obtain the comprehensive 3D view of the breast
volume which features U-Systems’ intuitive anatomical coronal
plane not available with conventional ultrasound systems.

"This license agreement will increase the adoption of Automated
Breast Ultrasound systems for women’s healthcare clinics wanting
the most advanced imaging technologies," said Ron Ho, President
and CEO of U-Systems. "Women’s healthcare and breast imaging is
strategic to both U-Systems and Siemens. We see significant
advantages in leveraging Siemens’ marketing and ultrasound
expertise with our advanced development competencies and look
forward to this partnership.”

source; U-Systems

iCAD announces availability of its SecondLook Digital with Planmed Nuance Full Field Digital Mammography Systems outside of U.S.

NASHUA, N.H., Dec 30, 2008 (BUSINESS WIRE) -- iCAD(R), Inc. , an industry-leading provider of Computer-Aided Detection (CAD) solutions, today announced that its SecondLook(R) Digital CAD technology customized for use with the Planmed Nuance FFDM system is now available outside of the U.S.

"When analyzing iCAD's SecondLook Digital CAD with Planmed Nuance Full Field Digital Mammography unit using selenium flat panel detector, it was found that the true positive findings detected at double reading of screening mammograms, were also marked accurately by CAD," said Dr. Martti Pamilo from Terveystalo, the leading private healthcare provider in Finland. "We are excited to see the results of the iCAD's SecondLook Digital CAD integration to the Nuance FFDM system," said Vesa Mattila, Vice President of Planmed. "As CAD is becoming widely accepted in Europe, iCAD's technology is an important addition to Planmed's digital mammography systems and solutions."

source: Marketwatch

Link Between Obesity and Breast Cancer in Postmenopausal Women Not Related to Frequency or Accuracy of Mammography

Researchers affiliated with the Breast Cancer Surveillance Consortium in the United States have reported that patterns of mammography use and mammography accuracy are not the reason for higher rates of advanced breast cancer in obese postmenopausal women. The results of this study were published in the December 3, 2008 issue of the Journal of the National Cancer Institute.[1]

Approximately 200,000 women are diagnosed with breast cancer every year in the United States. The majority of breast cancers are diagnosed among postmenopausal women. Previous research has indicated that postmenopausal women who are overweight or obese are at an increased risk of developing breast cancer.[2] Furthermore, being overweight or obese has been associated with larger tumor size and more advanced disease at diagnosis.[3]

source: CancerConsultants.com

U-Systems, Inc. Announces Technology Licensing Agreement with Siemens Healthcare

SAN JOSE, Calif., Dec 22, 2008 (BUSINESS WIRE) -- U-Systems, Inc., the innovative leader in dedicated breast ultrasound systems, today announced a technology licensing agreement with the Ultrasound Business Unit of Siemens Medical Solutions USA, Inc., Mountain View, California. The U-Systems' somo-VIEWer(TM)* advanced workstation for Automated Breast Ultrasound has been licensed for use with Siemens' ACUSON S2000 Automated Breast Volume Scanner (ABVS)** recently introduced at RSNA 2008. This will allow physicians to obtain the comprehensive 3D view of the breast volume which features U-Systems' intuitive anatomical coronal plane not available with conventional ultrasound systems.

"This license agreement will increase the adoption of Automated Breast Ultrasound systems for women's healthcare clinics wanting the most advanced imaging technologies," said Ron Ho, President and CEO of U-Systems. "Women's healthcare and breast imaging is strategic to both U-Systems and Siemens. We see significant advantages in leveraging Siemens' marketing and ultrasound expertise with our advanced development competencies and look forward to this partnership."

source: Marketwatch

Computer-Aided Mammography Finds More Cancer, More False Positives

Computer programs designed to help radiologists could identify more cases of breast cancer, but they might also increase the number of false positive results, which can lead to biopsies in healthy women, according to a recent systematic review.

Using computer-aided detection (CAD) mammography, “you do catch some cases that would have been missed if the mammogram had been read only by a single radiologist,” said review author Meredith Noble, a research analyst at ECRI Institute.
Amy Sutton

Typically, a radiologist examines a woman’s screening mammogram to check for signs of cancer. When using CAD with mammography, the radiologist still reads the mammogram, but a computer program also evaluates the mammogram and marks suspicious areas for the radiologist to review further.

Investigators led by Noble synthesized data from seven previously published studies of CAD mammography’s use in 392,015 healthy women with no lumps or other symptoms of breast cancer.

The current report, released this month, is an update of an earlier review also published by ECRI Institute, a nonprofit health services research agency that produces systematic evidence reviews on medical devices, drugs, biotechnologies and procedures.

source: Health Behavior News

New breast-imaging device Could be a safer alternative to conventional mammograms

The world's first radar breast imaging system developed at Bristol University that could revolutionise the way women are scanned for breast cancer, is being trialled at North Bristol NHS Trust (NBT).

Professor Alan Preece and Dr Ian Craddock from the University of Bristol have been working for a number of years to develop a breast-imaging device which uses radio waves and therefore has no radiation risk unlike conventional mammograms.

The team began developing and researching a prototype around five years ago and have received funding from organisations including the Engineering and Physical Sciences Research Council (EPSRC), the trustees of the United Bristol Hospitals and the University of Bristol spin-out company, Micrima Ltd.

Dr Ian Craddock from the University's Department of Electrical and Electronic Engineering, said: "This new imaging technique works by transmitting radio waves of a very low energy and detecting reflected signals, it then uses these signals to make a 3D image of the breast. This is basically the same as any radar system, such as the radars used for air traffic control at our airports."

source: Top Cancer News

Women At High Risk Of Breast Cancer May Benefit From Alternating Mammography And MRI

Magnetic resonance imaging (MRI) alternated with mammography at six-month intervals can detect breast cancers not identified by mammography alone, a research team from The University of Texas M. D. Anderson Cancer Center will report at the 31st at the CRTC-AACR San Antonio Breast Cancer Symposium.

MRI is known to be more sensitive in detecting breast cancers than mammography, with a 71 - 100 percent accuracy compared to a 16 - 40 percent accuracy for mammography. As a result, annual breast cancer screening for high-risk women now typically includes MRI along with mammography and a clinical breast exam.

source: Medical News Today

Mammography violations bring fines

The Nevada State Health Division has fined Desert Springs Hospital and Medical Center $1.14 million for more than 200 violations in its mammography department, including failing to document whether its mammogram system was operating as it should before some patient exams in 2007, health officials announced Wednesday.

Because of the violations, 92 patient records were missing, and the patients had to undergo additional screenings, the health division said.

The records in question, which Desert Springs officials said were misplaced, would have shown whether tests had been conducted to ensure the mammogram system was operating properly before the patients underwent mammograms, said Ed Sweeten, supervisor of the health division's Bureau of Health Quality and Compliance Radiological Health Section.

source: Las Vegas Review Journal

Cryoablation of Early Invasive Ductal Breast Cancer With MRI Confirmation Shows Promising Clinical Benefits

CHICAGO, Dec 05, 2008 /PRNewswire via COMTEX/ -- Early clinical experience with the FDA cleared Visica 2(TM) Treatment System from Sanarus Medical confirms the effectiveness of ultrasound guided cryoablation to completely eradicate small, unifocal Invasive Ductal Breast Cancer (IDC). Initial data from this multi-center study was presented at the 94th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), November 29 - December 5, 2008.

The study, "New Findings on Contrast-enhanced Magnetic Resonance Imaging, the "Black Hole" and "Cryohalo" are Markers for the Efficacy of Ultrasound-guided Cryoablation of Small Unifocal Invasive Ductal Breast Cancer," presented by Gary Levine, MD, Director of Breast Imaging at Hoag Breast Care Center in Newport Beach, Calif., was designed to evaluate the ability of breast contrast enhanced MRI to assess the effectiveness of ultrasound guided cryoablation for the local treatment of small, unifocal IDC.

source: Marketwatch

Declining Mammography Rates Mean More Women May Discover Cancer at Later Stages

Newswise — Risks versus rewards: it’s a simple equation we often use in making decisions. For women considering mammography, the decision should be easy, according to Scott Woomer, M.D., breast radiologist and interventionalist on the medical staff at Baylor Regional Medical Center at Grapevine.

“When you consider an hour out of your day usually once a year, some possible discomfort and the relatively low cost of mammography compared to not finding breast cancer at an early stage—which could save your life—it’s just not worth putting it off,” said Dr. Woomer.

A 2007 report from the American Cancer Society, however, shows that more women are putting it off. Mammography rates appear to be stabilizing or slightly declining after increasing for more than a decade, according to the report. Dr. Woomer partially credits this decline to women’s fears that mammography is painful.

“We’ve got to do a better job showing the steps we’ve taken to make mammography more comfortable,” said Dr. Woomer.

source: Baylor Health System

Molecular Breast Imaging Identifies Occult Cancer

Breast-Specific Gamma Imaging (BSGI) is shown to be an effective method of identifying mammographically and clinically occult (hidden) breast cancer. BSGI is a molecular breast imaging technique that can see lesions independent of tissue density and discover very early stage cancers. According to findings presented at the annual meeting of the Radiological Society of North America (RSNA) in this study of women where breast cancer was already suspected via mammogram or physical exam, BSGI identified additional suspicious lesions in 29 percent of the patients and found a previously unsuspected cancer in 9 percent of women.

"BSGI is an emerging technology that goes beyond mammography as an effective imaging procedure for early breast cancer detection," said Dr. Rachel Brem, Director of Breast Imaging and Intervention at George Washington University Medical Center in Washington, D.C., and Vice Chair of the Department of Radiology.

source: Dilon Technologies

Dual-Head Gamma Camera Significantly Increases Ability to Detect Breast Tumors Not Seen on Mammography

A dual-headed dedicated gamma camera used during molecular breast imaging (MBI) can accurately detect small breast tumors less than 2 cm in size, according to a study performed at the Mayo Clinic in Rochester, MN.

One-hundred fifty patients who had suspicious lesions smaller than 2 cm in size were imaged using dual-head molecular breast imaging. “There were 128 cancers confirmed in 88 patients,” according to Carrie B. Hruska, MD, lead author of the study. “The sensitivity rate of dual-head MBI during the study was 90% (115/128)”, she said.

“Dual head MBI involves a very light, pain-free compression of the breast. Two views of each breast are performed, lasting for about 10 minutes per view,” said Dr. Hruska. “The patient receives an IV injection of a commonly used radiotracer and this tracer circulates throughout the body and is preferentially absorbed in the breast cancer,” she said.

source: ARRS.org

Breast Cancer in Men: Mammography and Sonography Findings

Mammography and sonography findings help doctors identify and appropriately treat breast cancer in men, according to a study performed at the University of Texas M.D. Cancer Center in Houston, TX.

Image findings from 57 male patients who were diagnosed with breast cancer were reviewed during the study. “The findings show that breast cancer in men most commonly presents itself as a mass with an irregular shape and spiculated (spiky or pointy) margins that may or may not have calcifications. Many men in the study, 47%, also had cancer which had spread to the armpit,” said Wei Tse Yang, MD, lead author of the study.

Male breast cancer accounts for less than 1% of all breast cancers and “a large number of men with breast cancer do not undergo imaging prior to treatment either because mammography is not heavily advertised in the male community or because men also may be socially conscious about that part of their anatomy,” said Dr. Yang. “Almost 100% of men with breast cancer have a lump they can feel. Men should consult their physician and seek treatment as early as possible when a new mass presents itself in the breast,” she said.

source:ARRS

Toshiba Introduces MR Radiance Plus Breast Imaging Suite

CHICAGO, Nov 30, 2008 (BUSINESS WIRE) -- Advancements in medical imaging technology have significantly increased early detection and improved outcomes for patients with breast cancer. At this year's Radiological Society of North America (RSNA) annual meeting in Chicago, Nov. 30 - Dec. 5, 2008 (Booth #3429, South Hall), Toshiba will announce its Radiance Plus Breast Imaging Suite available on the Vantage Atlas(TM) and Vantage Titan(TM) MR systems. The new multi-channel Radiance Plus Breast Imaging Coil optimizes Magnetic Resonance Mammography (MRM) on the Vantage systems.

"Breast MR is effective in helping to diagnose breast cancer and the Radiance Plus Breast Imaging Suite is the latest technological advancement in improving image quality," said Bob Giegerich, director, MR Business Unit, Toshiba. "The higher signal-to-noise ratio created by the coil results in clearer images."

The bilateral, dedicated, multi-element Radiance Plus Breast Imaging Coil provides high temporal and spatial resolution for dynamic analysis and lesion characterization. The coil delivers a high signal-to-noise ratio, significantly increasing the breast image quality. The Radiance Plus Breast Imaging Coil is an addition to existing Vantage coils which are uniquely designed to improve workflow and patient comfort.

source: Toshiba

Siemens Introduces New Standard of Care for Breast Ultrasound

CHICAGO, Ill., Nov. 26 /PRNewswire-FirstCall/ -- Siemens Healthcare (http://www.siemens.com/healthcare) highlights the ACUSON S2000™ Automated Breast Volume Scanner (ABVS)(1), the world's first multi-use, automated volume breast ultrasound system, at the 94th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from November 30 to December 5 at McCormick Place (Booth #922, East Building/Lakeside Center, Hall D) in Chicago. Siemens also demonstrates how Tissue Strain Analytics(2), a new dimension of diagnostic information, and intelligent knowledge-based workflow solutions, empower physicians to leverage ever-increasing imaging information density to achieve greater diagnostic confidence and decreased study time.

According to the New England Journal of Medicine(3), dense breast tissue increases a woman's risk of breast cancer up to five-fold. While mammography remains the method of choice for breast cancer screening, a study(4) published by the RSNA in 2002 found that the detection rate for nonpalpable, invasive breast cancers increased by 42 percent when mammography was followed by an ultrasound examination.

source: Siemens

Stereotactic Breast Biopsy Made Easy with Mammomat Inspiration

Siemens Healthcare has introduced its new biopsy unit to the market, enhancing the Mammomat Inspiration digital mammography platform with stereotactic breast biopsy. The digital system with basic functions for screening has been on the market since the end of 2007. Since then, it has been installed in countless hospitals and private practices worldwide. The new device with its supplemental biopsy function recently went into operation in Copenhagen and Dortmund. Using the new system, all workflows are performed faster and easier than ever before.

The biopsy unit is easy to install; it simply slides on the full-field detector of the mammography platform. Using the same detector ensures that the radiographic image quality remains high. The mammography system detects the biopsy unit and automatically switches all hardware and software configuration settings to the biopsy mode. A preconfigured examination workflow and a well-defined user interface intuitively guide clinical personnel through the intervention.

source: Siemens Medical

PACSGEAR Launches PacsSCAN Film for Mammography at Upcoming RSNA Annual Meeting

PLEASANTON, CA - (November 25, 2008) – PACSGEAR, Inc., the leader in document and multimedia connectivity solutions for PACS/EHR, today announced the introduction of PacsSCAN Film™ for Mammography, an application specifically designed for digitizing film-based mammography images. The PacsSCAN Film for Mammography System scans plain film mammograms and allows side-by-side comparison with digital mammography images.

The product measurably improves radiologists’ reading times by employing the DICOM Digital Mammography standard. This standard enables the correct sequencing of scanned images on digital mammography workstations. Scanned images can be enhanced by using the company’s proprietary Dynamic Contrast Algorithm (DCA), which gives scanned film a digital look and feel. The PacsSCAN Film for Mammography software can be configured to display scanned images at the same resolution as their digital counterparts. Throughput is further enhanced with PACSGEAR’s patent-pending batch scanning technology.

source: PACSGEAR

Mammogram most effective 12 months after radiation treatment

Breast cancer patients who receive breast-conserving therapy and radiation do not need a follow-up mammogram until 12 months after radiation, despite current American Society of Clinical Oncology (ASCO) and National Comprehensive Cancer Network (NCCN) guidelines that recommend follow-up mammograms at between six and 12 months after radiation, according to a November 15 study in the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.

According to the American Cancer Society, more than 182,000 women will be diagnosed with breast cancer in 2008, and many of these women will choose to undergo a lumpectomy and radiation therapy as their course of treatment, which has been shown to produce similar survival outcomes to a mastectomy. Mammography has been established as a crucial part of post-treatment surveillance for patients undergoing breast-conserving therapy, but the optimal timing of the initial mammogram is not clear.

source: ASTRO

Screening for Breast Cancer May Spur Unnecessary Treatment

Michelle Fay Cortez

Nov. 25 (Bloomberg) -- Mammograms may lead to unneeded treatments for breast cancer that might have regressed naturally, according to new research that revives a debate over frequent screening.

Doctors and public health officials have debated the risks and benefits of regular mammograms for years. While the common assumption is that finding small, easily treated tumors will prevent the development of larger, deadly cancers in the future, studies have yielded mixed results.

The report, published today in the Archives of Internal Medicine, found that the rate of cancer among women who received biannual mammograms over six years in four Norwegian countries was 22 percent higher than those who didn’t. That may mean that tumors in those who weren’t tested regressed without being treated, researchers said.

“Our findings simply provide new insight on what is arguably the major harm associated with mammographic screening, namely, the detection and treatment of cancers that would otherwise regress,” said the researchers led by Per-Henrik Zahl at the Norwegian Institute of Public Health‘s epidemiology department in Oslo.

source: Bloomberg News

Ultrasound elasticity measures tissue stiffness for more accurate breast imaging

Elasticity is an ultrasound technique that provides additional information about the stiffness of breast lesions for a more accurate diagnosis. The ACUSON S2000™ ultrasound system from Siemens Healthcare features eSie Touch™ elasticity imaging to enable this emerging technique. Although mammograms are the standard diagnostic tool for breast scans, ultrasound can be beneficial to patients that need regular examinations or have denser breast tissue such as younger women and patients on HRT.

Like a manual self-exam but more sensitive, eSie Touch elasticity imaging generates an elastogram that gauges how much tissue moves when pushed, so that it can detect how soft or stiff an object is. More detailed information from ultrasound means that some patients are not only spared an uncomfortable, invasive procedure such as needle biopsies, but are also provided with results on a much shorter timescale.

Dr. William Svensson, Consultant Radiologist and Reader in Breast Imaging at Imperial College Healthcare NHS Trust, has undertaken extensive research into elastography for breast cancer diagnosis and trialled the ACUSON S2000 from Siemens. He states, “Elasticity is an ultrasound modality that detects subtle tissue stiffening. Whilst it is a relatively new technique, increasing skill in interpreting its results has the potential for increasing the accuracy of diagnosis. It certainly has the potential in the long term to reduce the number of biopsies carried out by detecting benign lesions with greater accuracy.”

source: Siemens Medical

Naviscan Receives 510(k) Clearance for Stereo Navigator(TM) - the First Commercially Available Breast PET-Guided Biopsy Feature

SAN DIEGO, Nov. 19 /PRNewswire/ -- Naviscan, Inc., announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its biopsy-guidance feature designed exclusively for use with its high-resolution organ-specific PET scanner. The scanner's breast application is Positron Emission Mammography (PEM).

Stereo Navigator(TM), the PEM-guided biopsy accessory, is indicated for the localization of lesions in female breasts, as identified on a PET image. This guidance system will now enable physicians to guide compatible interventional devices towards abnormalities visible on PET.

This Stereo Navigator biopsy feature represents the cutting edge of targeted molecular imaging in the breast. The accessory uses a stereotactic frame fixed between the scanner's paddles to guide the insertion of a compatible interventional device into the breast. Accurate targeting is possible due to the high-resolution 3-D tomographic images acquired.

source: PR Newswire

Parascript Announces AccuDetect 2.0 Computer Aided Detection Algorithms for Greater Accuracy in Assessing Mammograms

BOULDER, Colo., Nov. 17 /PRNewswire/ -- Parascript, LLC, the image analysis and pattern recognition technology provider, today announced the release of AccuDetect 2.0, the next generation of its computer-aided detection (CAD) algorithms for mammography. Parascript AccuDetect 2.0 is even more robust with improved performance and increased potential for lowering false-positive rates in detecting suspicious lesions on mammograms. Available for OEM customers interested in reducing false-positive rates of existing CAD systems, AccuDetect is intended to assist radiologists in the early detection of breast cancer during film-based or digital mammography exams.

CAD systems are typically relied upon to identify and highlight hard-to-find features and anomalies on medical images that may be indicative of cancer and bring them to the attention of radiologists. AccuDetect is an enabling technology that easily integrates with existing analog and digital CAD systems to improve the accuracy of data interpretation. Its primary objective is to enable existing CAD systems to reduce false-positive readings through the utilization of voting methodology in medical imaging.

source: Parascript

Advanced Imaging Technologies to Limit Breast and GI Biopsy Procedures

WALTHAM, Mass., Nov. 12/PRNewswire/ -- According to Millennium Research Group's (MRG's) US Markets for Biopsy Devices 2009 report, the popularity of advanced imaging technologies will restrict the number of gastrointestinal (GI) and breast biopsy procedures performed through 2013.

The availability of endoscopes with microscopic capabilities for visualizing tissue at the cellular level has decreased the requirement for a biopsy in endoscopic GI procedures. PENTAX's Confocal Endomicroscope, for example, enables physicians to examine inner structures at extreme magnifications, in some cases allowing for diagnosis without the need for a biopsy. Should additional competitors enter the endomicroscopy market, unit growth for GI biopsy forceps will slow.

"Likewise, breast biopsy procedures will be affected by advanced imaging technologies," says Sarah Leonard, Analyst at MRG. "Improvements in breast imaging technology are leading to more accurate evaluations of suspected breast cancers, potentially reducing the need for breast biopsies. In particular, breast MRI, breast-specific gamma imaging, and positron emission mammography provide information that can help determine whether a suspicious lesion is benign or malignant, boosting the appeal of diagnostic breast imaging and slowing growth in the number of breast biopsies being performed.

source: PR Newswire

New technology could revolutionise breast cancer screening

The world's first radar breast imaging system developed at Bristol University that could revolutionise the way women are scanned for breast cancer, is being trialled at North Bristol NHS Trust (NBT).

Professor Alan Preece and Dr Ian Craddock from the University of Bristol have been working for a number of years to develop a breast-imaging device which uses radio waves and therefore has no radiation risk unlike conventional mammograms.

The team began developing and researching a prototype around five years ago and have received funding from organisations including the Engineering and Physical Sciences Research Council (EPSRC), the trustees of the United Bristol Hospitals and the University of Bristol spin-out company, Micrima Ltd.

Dr Ian Craddock from the University's Department of Electrical and Electronic Engineering, said: "This new imaging technique works by transmitting radio waves of a very low energy and detecting reflected signals, it then uses these signals to make a 3D image of the breast. This is basically the same as any radar system, such as the radars used for air traffic control at our airports."

source: University of Bristol

Clinical Study Using the Aurora® Breast MRI System Recommends the Use of Breast MRI for Preoperative Evaluation of Newly Diagnosed Breast Cancer Patie

NORTH ANDOVER, Mass. (Nov. 10, 2008) – Aurora Imaging Technology Inc. is proud to announce that the Aurora® Dedicated Breast MRI System was exclusively utilized in a large clinical study that demonstrated the significance of preoperative breast MRI for newly diagnosed breast cancer patients, while producing no delay in treatment. The study, co-sponsored by Mercy Health Center and Breast MRI of Oklahoma LLC, was published by the American Journal of Surgery. Alan Hollingsworth, M.D., medical director and breast surgeon at Mercy Women’s Center at Mercy Health Center in Oklahoma City, and his colleagues included 603 patients from March 2003 through December 2006 – the largest single-site study of preoperative patients ever published on MRI for breast cancer.

“Contrary to the speculative criticisms about breast MRI today, one of the most notable findings in our study is that women who underwent breast MRI had a better chance of avoiding mastectomy,” said Dr. Hollingsworth. “In fact, we present evidence that the number of breast conservation surgeries after MRI increased 12 percent to a rate slightly higher than the national data as reported by the National Cancer Data Base from the American College of Surgeons Commission on Cancer. Our study concludes that breast MRI is a valid recommendation for preoperative evaluation of newly diagnosed breast cancer patients.”

source: Aurora

Dilon Technologies Partners With PenRad Mammography Information Systems to Provide Streamlined Diagnostic Analysis and Reporting

NEWPORT NEWS, Va., Nov. 6 /PRNewswire/ -- Dilon Technologies announced today that they have entered into a co-marketing partnership with PenRad Mammography Information Systems. Dilon will introduce the PenRad system to its Dilon 6800 Gamma Camera customers as a tool to effectively streamline patient exam analysis and reporting.

The Dilon 6800 Gamma Camera is a high-resolution, small field-of-view gamma camera, optimized to perform Breast-Specific Gamma Imaging (BSGI), a molecular breast imaging procedure that images the metabolic activity of breast lesions through radiotracer uptake. The PenRad MIS auditing and tracking system creates efficiencies for clinics and hospitals where BSGI is performed. The software helps facilities meet MQSA requirements by creating reports, patient letters, statistics, analytics, and more. PenRad's unique design benefits the patient, technologist, radiologist and
administrative office personnel, increasing the productivity and profitability of a practice.

source: PR Newswire

Aurora Imaging Technology Receives FDA Clearance for Spectroscopy Technology

NORTH ANDOVER, MA. (Nov. 3, 2008) – Aurora Imaging Technology Inc. is proud to announce that the Aurora® 1.5Tesla Dedicated Breast MRI System has received 501(k) clearance from the U.S. Food and Drug Administration (FDA) for AuroraSPECTROSCOPY™, the company’s breast magnetic resonance (MR) spectroscopy package. The availability of AuroraSPECTROSCOPY will provide Aurora Breast MRI the capability to perform in vivo breast MR spectroscopy (MRS) and MR spectroscopic imaging (MRSI). AuroraSPECTROSCOPY was developed to supplement Aurora Breast MRI by further improving the image specificity of this groundbreaking technology. The Aurora Breast MRI remains the only FDA-cleared dedicated breast MRI system specifically designed for the detection, diagnosis and management of breast disease alone.

“The introduction of AuroraSPECTROSCOPY is another example of Aurora’s commitment to offering promising tools and technology to aid medical professionals in combating breast disease through early detection and improved treatment planning,” said Olivia Ho Cheng, president and chief executive officer, Aurora Imaging Technology.

sourceAurora Imaging

Susan G. Komen Breast Cancer Foundation awards grant for imaging-agent research

CLEMSON — Clemson University researchers developing imaging agents to allow a new method of detecting breast cancers have received $180,000 from the Susan G. Komen Breast Cancer Foundation. Breast cancer is the second leading cause of cancer deaths in American women.

The new method allows for a combination of light and MRI (magnetic resonance imaging) that may help researchers look at different parts of cells and tissues.

Clemson chemistry professor and principal investigator Ya-Ping Sun said the funding will play a major role in further developing Clemson technologies on fluorescent carbon nanomaterials, dubbed “carbon dots”, by implanting magnetic elements into the dots. This will serve as a contrast agent for both light- and magnetic-imaging techniques for the early detection and diagnostics of breast cancers and beyond. Li Cao, a research scientist in Sun’s research group, will carry out the research project.

source: Clemson University

Women with Breast Implants Encouraged To Go Beyond Regular Mammogram Screening

Norwalk, CT (PRWEB) October 28, 2008 -- NewImage.com, the premier online destination for personal image enhancement solutions, is pleased to support National Breast Cancer Awareness Month for a second year by helping raise awareness of the importance of early detection and encouraging women with breast implants to go beyond regular mammography screenings to reduce the risk of possibly missing a tumor hidden under an implant.

During National Breast Cancer Awareness Month, NewImage.com wants every woman with breast implants to feel confident about the precautions she is taking against breast cancer. In addition to regular mammography screenings, monthly breast-self exams and a risk assessment from a physician, NewImage.com suggests* women with breast implants to be extra cautious and educate themselves about the risks and responsibilities that come with undergoing breast augmentation.

source: eMediaWire

Mammography Equipment Market to Surpass $1.1 Billion by 2015, According to New Report by Global Industry Analysts, Inc

San Jose, California (PRWEB) October 27, 2008 -- Globally, rising awareness about breast cancer has allowed women to come forward for their yearly mammograms after the age of 40 years or earlier, if required. Mammography is recommended as standard screening process for breast cancer globally, resulting in increased adoption of such procedures. A major driving force for the worldwide market for mammography equipment is the fact that one out of every eight women in industrialized countries faces the risk of being affected by breast cancer.

United States and Europe account for about 80% of global volume sales of mammography equipment Technological innovations such as computer-aided detection (CAD) and digital mammography, as well as emerging technologies such as thermal mapping and optical imaging are expected to offer positive growth prospects for the market, as stated in a recent report published by Global Industry Analysts, Inc. Analyzing segment-wise, the Digital mammography equipment market is estimated at US$610 million for 2008. Growth in the segment is driven by numerous technological advantages that ensure improved imaging, rapid scanning, and convenient usage. Although the growth of Full field digital mammography (FFDM) segment in the initial years was almost negligible, the outlook is changing due to proven usage in screening procedures. In the United States, Full field digital mammography market is projected to reach US$677 million by 2015.

source: PR Web

How coloured lights help with breast scans

James Connell

A visit to the hospital for an intimate examination can be distressing, nervewracking and embarrassing for some patients. Now the use of coloured “MoodLight” during breast examinations at Worcester’s main hospital may be the latest way to, quite literally, banish patient blues.

The new machine has been ordered by staff at Worcestershire Royal Hospital in Newtown Road, Worcester, to help put patients at ease.

The machine uses “warm and soothing tones” to reduce patient anxiety during examinations.

It is the first time in the county’s hospitals that the use of colour in technical breast examinations has been used to help relax patients during awkward and sometimes embarrassing procedures.

source: Worcester News

3-D Doppler Ultrasound Helps Identify Breast Cancer

OAK BROOK, Ill. — Three-dimensional (3-D) power Doppler ultrasound helps radiologists distinguish between malignant and benign breast masses, according to a new study being published in the November issue of Radiology.

"Using 3-D scans promises greater accuracy due to more consistent sampling over the entire tumor," said lead author, Gerald L. LeCarpentier, Ph.D., assistant professor in the Department of Radiology at University of Michigan in Ann Arbor. "Our study shows that 3-D power Doppler ultrasound may be useful in the evaluation of some breast masses."

Malignant breast masses often exhibit increased blood flow compared to normal tissue or benign masses. Using 3-D power Doppler ultrasound, radiologists are able to detect vessels with higher flow speeds, which likely indicate cancer.

source: RSNA

Breast Imaging and Reporting Data System Subcategories Improve Diagnostic Accuracy in Mammographic Reports: Presented at ASCP

BALTIMORE, Md -- October 17, 2008 -- Use of Breast Imaging and Reporting Data System (BI-RADS) subcategories by radiologists can help improve the accuracy of breast cancer diagnoses, according to research presented here at the American Society for Clinical Pathology (ASCP) 2008 Annual Meeting.

Mary Ann Sanders, MD, PhD, University of Louisville School of Medicine, Louisville, Kentucky, and colleagues conducted their study to determine the diagnostic accuracy of BI-RADS subcategory 4 diagnosis of mammograms by radiologists. Dr. Sanders presented the results on October 16.

Mammograms can now be subcategorised according to American College of Radiology criteria. "Levels 1 to 3 are benign lesions, and level 5 will almost always turn out to be malignant. Level 4, however, will turn out to be malignant in 30% of cases," she explained.

source: Doctors Guide

Medipattern's B-CAD(R) Increases Diagnostic Accuracy on Small Breast Cancer Lesions

The Medipattern Corporation (TSX VENTURE:MKI - News), a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, is pleased to announce that a study abstract, showing a statistically significant increase in diagnostic accuracy when using B-CAD Version 2 on lesions less than 1 cm in size, has been published in the October 2008 issue of the American Journal of Clinical Oncology.

The study was conducted at the PLA301 Hospital in Beijing, China using the global version of B-CAD Version 2, and reported in the paper: "The Value of Computer-Aided Detection for Breast Ultra-Sonography (B-CAD) in the Diagnosis of Breast Cancer" by principal authors Dr. Jun Lai Li and Dr. Dan Fei Song. The study is based upon 100 confirmed biopsied cases, comparing the diagnostic accuracy of three reading scenarios: a single physician, double reading with two physicians, and a single physician reading with B-CAD. The accuracy of the single physician increased with B-CAD in all categories. The most striking result shows a statistically significant 44 percent improvement in diagnostic accuracy for the single reader with B-CAD V2 on lesions less than 1 cm in size (n equals 9).

source: Medipattern

SNM Releases New Fact Sheet on Breast Cancer and Molecular Imaging

RESTON, Va.—Coinciding with the observance of Nuclear Medicine Week (October 5 to 11) and National Breast Cancer Awareness Month (October), SNM released today a new fact sheet highlighting recent developments in molecular imaging technologies that are dramatically improving the ways in which breast cancer is diagnosed and treated.

Molecular imaging is a highly effective, safe and painless imaging tool for diagnosing and treating breast cancer. Physicians report that the information they have gained from molecular imaging technologies has resulted in decisions to change the course of treatment in between 24 and 48 percent of breast cancer cases.

Breast cancer is just one of many types of cancer for which new and emerging molecular imaging techniques and therapies can significantly improve detection, diagnosis and treatment.

source: SNM

Single Mammography Reading With Computer-Aided Detection Is Viable Alternative to Double Reading

October 2, 2008 — Previous studies have shown that double reading of mammograms can improve breast cancer detection and is standard practice in about a dozen European countries. However, a study in the current October 1 online issue of the New England Journal of Medicine found that a single reading with computer-aided detection is a viable alternative to double reading for screening mammography. In addition, computer-aided detection can improve the rate of identifying malignant lesions in mammograms read by a single reader.

The researchers found that the proportion of cancers detected by a double reading was 199 (87.7%) of 227 compared with 198 (87.2%) of 227 for a single reader using computer-aided detection. The sensitivity, specificity, and positive predictive values were also similar between the 2 methodologies.

source: Medscape

Anoto Digital Pen Cuts Mammogram Analysis From Hours To Minutes In France

Sweden-based Anoto Group AB, the inventor of the Anoto Digital Pen and Paper technology, announces its tremendous success in reducing waiting lists for breast cancer screening by significantly shortening the time it takes to analyze mammograms. The digital pen has been implemented in France's "Plan Cancer" program to combat this growing public health concern.

Since 2003, France offered a systematic and organized breast cancer screening for women between the age of 50 and 74 contributing to regularity of screening tests. An alarming 40,000+ new breast cancer cases reported each year inspiring the program which participates are invited to testing via a mammography ever other year. A women's anxiety rises with waiting for breast cancer results.

source: Medical News Today

New test for breast tumors: Water ultrasound imaging seems as accurate as mammography

DETROIT – You're lying face down on a massage table, your breast encased in a water bath through an opening in the table. Tiny ports from a surrounding ring fire ultrasound waves. There are no X-rays. There is no pain. There is no holding still for 20 minutes or more.

And in the time it takes to finish reading this paragraph, you will have safely and cheaply completed a high-definition, 360-degree mammogram, courtesy of an ultrasound imaging machine in experimental stages at the Karmanos Cancer Institute. Its inventors think it will soon become the preferred method for detecting and monitoring breast tumors.

source: Dallas News

First Accredited CME Course on BSGI - the Molecular Breast Imaging Exam, Now Available to All Physicians

NEWPORT NEWS, Va., Sept. 25 /PRNewswire/ -- The Institute for AdvancedMedical Education in partnership with WebMedEd and Applied Radiology nowoffers an online CME course on Breast-Specific Gamma Imaging (BSGI), amolecular breast imaging exam. The course is designed to educate physicians onthe utility of BSGI as a critical adjunct procedure to mammography, ultrasoundand MRI to help diagnose early stage breast cancers, particularly types thatcan be difficult to detect, such as DCIS and lobular carcinoma.

The program is accredited for Two (2) AMA/PRA CME Credits(TM) and isdivided into a five-module presentation. Dr. Margaret Bertrand with SolisBertrand Breast Center in Greensboro, NC presents an "Interpretation andComparison to Other Modalities" and Dr. Ward Parsons with The Rose BreastCenter in Houston, TX presents "A Molecular Imaging Complement To BreastDiagnostics: Technology and Clinical Indications." The online course alsoincludes several case presentations from each physician, as well as aninterview session covering some of the most talked about topics in molecularbreast imaging.

source: International Business Times

MBI better than mammography for dense breast tissue

There may be a more effective way to detect breast cancer in women with dense breasts, according to a study released Sunday.

Molecular breast imaging (MBI) detects three times as many breast tumours as mammography in high-risk women with dense breast tissue, researchers at the Breast Cancer Symposium in Washington said.

MBI is a relatively new screening method wherein patients are injected with a radioactive agent that is absorbed by breast tissue. Cancer cells absorb more of the agent than healthy cells. A specialized camera tracks the agent and can distinguish between healthy tissue and cancer tumours.

source: CTV.ca News

Radiation Medical Group Is First In USA To Offer New Breast Cancer Treatment Option

Radiation Medical Group, Inc. is the first center in the nation to use a new version of the SAVI applicator for radiation treatment of breast cancer, potentially expanding the number of women who will qualify for breast brachytherapy.

RMG is the first center to use the SAVI™ 6-1Mini applicator, which is designed for the delivery of radiation to small or hard-to-treat lumpectomy cavities. The new device makes a shorter, more convenient form of radiation therapy available to more women.

"We are proud to be the first center to offer this new SAVI applicator option," said Gina Mansy, M.D., a radiation oncologist at RMG. "We are committed to providing women with state-of-the-art technology and the latest treatment breakthroughs, to arm them in the fight against breast cancer."

source: Radiation Medical Group

Surveillance mammography after treatment for primary breast cancer

The National Institute for Health Research Health Technology Assessment (NIHR HTA) programme has commissioned a new study to identify the most effective and efficient surveillance methods for women who have received treatment for primary breast cancer. There are 45,000 new cases in the UK each year and although the majority of women never experience a recurrence, it does return in approximately 25 per cent of women. The majority of these recurrences are found during the first three years after treatment.

It is generally accepted that early diagnosis is a key factor influencing survival from breast cancer, with an 81 per cent reduction in mortality compared with women who were identified with more advanced stages. A recurrence of breast cancer might be found either by physical examination or by mammography, a process which uses low-dose X-rays to examine the breast. There is, however, no general agreement as to the best way to monitor patients for recurrence or how often women should receive X-rays.

source: National Coordinating Centre for Health Technology Assessment

New Data On Breast Imaging Using Cardiolite(R) To Be Presented At ASCO Breast Cancer Symposium

Lantheus Medical Imaging, a worldwide leader in diagnostic imaging, announced that the company's leading imaging agent, Cardiolite® (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection) will be featured in a new study on molecular breast imaging being presented on Sunday, September 7, 2008, at 7:00am -12:00pm (EDT) as part of the poster sessions (abstract #68) at the American Society of Clinical Oncology's 2008 Breast Cancer Symposium in Washington, DC.

"This promising new study on molecular breast imaging provides encouraging data for millions of women and families who are impacted by breast cancer and sheds light on potential new diagnostic approaches for finding tumors in women who have dense breast tissue, which can confound mammograms," stated Don Kiepert, president and chief executive officer of Lantheus Medical Imaging. "We are proud to supply the imaging agent for this important clinical effort. Breast cancer is a devastating disease and we recognize how important and valuable early detection is for women."

source: Lantheus Medical Imaging

Molecular Breast Imaging More Effective than Mammography at Detecting Cancer in High-Risk Women with Dense Breasts

In the largest study to date to compare a screening technique called molecular breast imaging (MBI) to mammography, researchers have shown that MBI can detect three times as many cancers in women who have dense breast patterns on their mammogram and are at increased risk of breast cancer.

Mammography is the current standard of care for breast cancer screening. However, it can be difficult to distinguish normal breast tissue from tumor tissue in women with dense breasts using mammography. As a consequence, women who have dense breasts as well as other breast cancer risk factors often need additional screening.

MBI is a relatively new screening method in which patients are injected with a short-living radioactive agent that is absorbed by breast tissue. This agent is tracked with a specialized camera that can distinguish healthy tissue from breast cancer tumors, as cancer cells absorb more of the radioactive agent
than healthy cells. MBI is currently available at a limited number of cancer centers, but its availability is growing. While more expensive than mammography, MBI is about one-fifth of the cost of breast MRI (magnetic resonance imaging).

source: ASCO

PresGar Implements RamSoft's Digital Mammography Software

Less than a year into the process, RamSoft, a leading developer of affordable healthcare information technology, has successfully helped PresGar, the nation's largest privately-owned medical imaging service company, establish a significant digital mammography presence at eight of its imaging centers.

The result has been increased efficiency among PresGar mammographers and technologists and substantial savings for the company. If things go as planned, a ninth center may soon join the mix, combining RamSoft's PowerServer PACS and Gateway Routers with PresGar's new digital mammography system.

source: Medical News Today

Manhattan Diagnostic Radiology First in New York City to Offer Positron Emission Mammography (PEM) Scanner From Naviscan

NEW YORK, Aug 13, 2008 /PRNewswire via COMTEX/ -- Manhattan Diagnostic Radiology announced today that it will be the first imaging facility in Manhattan to offer Positron Emission Mammography (PEM) in the fight against breast cancer. This installation will provide Manhattan Diagnostic Radiology an increased ability to image and diagnose early-stage breast cancers, positively impacting cancer management. The leading-edge technology provides unprecedented metabolic resolution down to 1.5 millimeters.

"We recently received prestigious designation as a Breast Imaging Center of Excellence from the American College of Radiology acknowledging our commitment to providing the highest level of breast care to our patients," said Craig H. Sherman, M.D., Senior Partner and Director of PET/CT imaging at Manhattan Diagnostic Radiology. "We have always sought out the very best in diagnostic imaging technology, and PEM will be the latest in a long list of firsts for our center. We expect that PEM will prove indispensable to effective breast cancer management for both our referring physicians and our patient population."

source:Naviscan

“Convenience” of Screening Mammography Facilities Plays Major Role in Patient Retention

Patients cite “convenience to home or work” as the main reason they changed mammography facilities, according to a recent study conducted by researchers at the University of Cincinnati Medical Center and The Barrett Center in Cincinnati, OH.

The study included 303 current mammography patients (“stayers”) and 117 patients who no longer received mammography at the university-based center (“leavers”), said Mary C. Mahoney, MD, lead author of the study.

The study showed that among the “leavers” 37% cited convenience to home or work as the reason for leaving the university-based site and choosing a new mammography provider. Other reasons for leaving the university-based site included difficulty scheduling appointments (15%); 14% of those who left the university-based center indicated that their current mammography provider was mandated by their insurance provider.

source: ARRS

iCAD Achieves Record-High Ratings in Mammography CAD User Satisfaction

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early detection of cancer, today announced that the Company has achieved record-high customer satisfaction ratings in the Mammography CAD market, according to the independent healthcare research group MD Buyline.

In MD Buyline’s User Satisfaction Report for the first two quarters of 2008, iCAD remains #1 in mammography CAD for user satisfaction in system performance, system reliability, installation/implementation, applications training, service response time and service repair quality compared to Hologic/R2. Additionally, iCAD has attained record-high customer service ratings in the categories of System Reliability, Service Repair Quality and overall service and quality.

source: iCAD

Lidocaine Gel Could Make Mammograms More Comfortable

Mammograms are not one of the Top 10 things women look forward to each year. In fact, they may be in the Bottom 10, or even the Bottom 3. While they don't compare to the pain of surgery or childbirth, mammograms are an uncomfortable procedure for most women, but one that is considered a necessary evil. It is easy for many women to wince at the first thought of getting their screening for breast cancer. But help may be a smear away.

A new study conducted shows that a numbing gel could ease the pain associated with getting a mammogram and may make women more likely to come back for subsequent screenings. The lead author of the study said that the gel might act as a simple secret weapon: "We now have something that we know reduces discomfort with screening mammography in women who expect higher discomfort—lidocaine gel."

source: Healthnews

Aurora(R) Breast MRI Society Debuts The Journal Of Breast MRI

North Andover, Mass. – The Aurora® Breast MRI Society, a rapidly growing group of dedicated breast radiologists committed to advancing the use of cutting-edge dedicated breast MRI technology, previewed the newly developed Aurora Breast MRI Society Global PACS Teaching Tool. The teaching tool was introduced before an audience of more than 100 radiology professionals in attendance at the second annual Aurora Breast MRI Society Meeting, recently held in Newport Beach, Calif.

“The establishment of the Aurora Breast MRI Society Global PACS Teaching Tool is incredibly exciting, as it will provide Society members an exclusive Internet-based community in which they are able to network with colleagues, share clinical knowledge and data, enhance professional development, and improve the management and treatment of breast disease,” said Kamilia F. Kozlowski, M.D., president, Aurora Breast MRI Society, and medical director/CEO and clinical breast radiologist, Knoxville Comprehensive Breast Center. “We are proud of the progress made in supporting our Society�s mission through the introduction of the Aurora Breast MRI Society Global PACS Teaching Tool and know that this will be a very valuable tool for all practitioners using it.”

source: Aurora Breast MRI Society

Scientist Presents New Breast Cancer Imaging Method

Flemming Forsberg, Ph.D., professor of Radiology at Jefferson Medical College of Thomas Jefferson University, presents updated results on the effect of using subharmonic imaging (SHI) in determining a breast cancer diagnosis at the Fifth Era of Hope meeting in Baltimore, Maryland. SHI – a new breast cancer imaging technique – appears to improve the diagnosis of breast cancer relative to conventional ultrasound and mammography.

“With these recent findings, SHI could provide a major improvement to breast imaging and patient care,” said Dr. Forsberg.

source: EmaxHealth

Experimental Imaging System Helps Detect Breast Cancer

(HealthDay News) -- Researchers have devised a new breast-imaging technology that appears to be as accurate as MRI scans but several times cheaper.

The technique, called molecular breast imaging (MBI), is still in the early stages of development, the scientists added.

"We envision MBI being useful for women who are not served well by mammography, those who have mammographically dense breast tissue, and those at increased risk for breast cancer," said study author Carrie Beth Hruska, a research fellow at the Mayo Clinic in Rochester, Minn. "We have been working on the technology for the last six years. However, there are a lot of technical challenges that have had to be overcome, so it's still in the very early stages for use in patients."

source: US News & World Report

Online Radiology Offers Telemammography Services

Riverside, CA (PRWEB) June 23, 2008 -- Jesse Salen, the VP of Sales and Technology at Online Radiology Medical Group, Inc., announced last week, telemammography services are now available to its patients. According to Mr. Salen, "We opted to expand our slate of services with the intention of contributing to improving survival rates among breast cancer patients."

It is widely known that early detection through mammography is the most effective method of improving survival rates for breast cancer, a leading cause of death among women. Telemammography is the electronic transmission of digitized mammograms and provides greater efficiency in the area of breast imaging and interpretation. It significantly improves breast cancer screening by delivering critical medical expertise that is both timely and accurate.


source: PR Web

Fujifilm Introduces Breast Imaging Diagnostic Workstation

Stamford, CT. - June 19, 2008 - Fujifilm Medical Systems USA, Inc. announced today that it is introducing the Breast Imaging Diagnostic Workstation (BIDW). Available for any U.S. facility that has implemented Full Field Digital Mammography (FFDM), the BIDW is being introduced specifically to complement Fujifilm’s Computed Radiography for Mammography (FCRm) solution and provide better workstation interpretation capabilities for facilities that may use another vendor’s PACS. Delivering full Synapse® PACS functionality, this new standalone workstation is designed to be a supplement to any facility’s existing PACS, and meet the market need for more clinically and operationally advanced systems to support breast imaging.

“As more and more facilities adopt digital mammography, there is an increased need for PACS that provide the specialized features and advanced technologies that are so vital to the interpretation of full field digital mammography exams,” explained Jim Morgan, Fujifilm’s Director of Marketing, Network Systems. “Synapse is an advanced PACS that is uniquely capable of providing the diagnostic and clinical tools that radiologists demand for FFDM. The Breast Imaging Diagnostic Workstation will now enable customers that might already have an existing PACS to benefit from full Synapse capabilities and additional features specifically designed for digital mammography when interpreting their FFDM studies.”

source: Fuji

STAMFORD, Conn., June 19 /PRNewswire/ -- Fujifilm Medical
Systems USA, Inc. announced today that it is introducing the
Breast Imaging Diagnostic Workstation (BIDW). Available
for any U.S. facility that has implemented Full
Field Digital Mammography (FFDM), the BIDW is being
introduced specifically to complement Fujifilm's Computed
Radiography for Mammography (FCRm) solution and
provide better workstation interpretation capabilities for facilities
that may use another vendor's PACS. Delivering full Synapse(R)
PACS functionality, this new standalone workstation is designed
to be a supplement to any facility's existing PACS, and meet the
market need for more clinically and operationally advanced
systems to support breast imaging.

"As more and more facilities adopt digital mammography, there
is an increased need for PACS that provide the specialized
features and advanced technologies that are so vital to the
interpretation of full field digital mammography exams,"
explained Jim Morgan, Fujifilm's Director of Network
Systems.
source": Earth Times

Women's Imaging Centre First In Louisiana To Deploy Advanced Diagnostic Imaging With The Aurora Dedicated Breast MRI

Aurora Imaging Technology Inc. announced that the Aurora® 1.5Tesla Dedicated Breast MRI System is immediately available to patients for the first time in Louisiana at the Women's Imaging Centre-Lafayette.

The Aurora System is the only Food and Drug Administration (FDA) cleared dedicated breast MRI system specifically designed for the detection, diagnosis and management of breast disease. The Women's Imaging Centre chose the Aurora System to service patients in Lafayette, La. and its surrounding parishes to offer advanced diagnostic imaging, and address the staggering breast cancer statistics in Louisiana.

source: Medical News Today

Mammography Facility Characteristics Associated With Accuracy Of Screening

Some characteristics of mammography facilities are associated with the accuracy of interpretation of screening mammograms, according to a study published online June 10 in the Journal of the National Cancer Institute.

Previous studies have suggested that patient characteristics, such as age, are associated with variations in the accuracy of screening mammograms. Similarly, characteristics of the radiologist who interprets the mammograms, such as his or her reading experience, are associated with variations in accuracy. The impact of the type of facility or its characteristics on mammogram accuracy was unknown, but the information could help identify better practices and better places to obtain a mammogram.

source: Medical News Today

Sectra MicroDose Mammography honored with 2008 Medical Design Excellence Award

The IT and medical-technology company Sectra has been honored with 2008 Medical Design Excellence Award for Sectra MicroDose Mammography™. The system features superior image quality, an ergonomic design combined with a unique photon-counting technology enabling the lowest radiation dose on the market.

The jury’s motivation was: “Sectra MicroDose Mammography with its ultra low-dose radiation output and elegant ergonomics clearly stood out with regard to both the criteria patient safety and ease-of use. Aesthetics, while not absolutely critical, is also important and the elegant European form factor was another positive.”

source: SECTRA

Canadian Breast Cancer Network Releases 2008 Breast Cancer Wait Times

WINNIPEG, June 5 /CNW/ - New data collected by the Canadian
Breast Cancer Network (CBCN) shows that not all Canadian
women are receiving equal access to breast cancer
treatment. The CBCN presented the 2008 Breast Cancer
Wait Time in Canada Report Card findings
today at the 5th World Conference on Breast Cancer in
Winnipeg. "This Report Card is a call to action for
concerned organizations and individuals to work
collaboratively to find solutions to breast cancer
issues," said Diana Ermel, president of the CBCN.
"Breast cancer wait times and accessibility to
medications must remain high on the public
agenda to improve access and quality of care."
While many jurisdictions are working on innovative
solutions to shorten wait times, there continue
to be significant gaps in the current standards of
care across the country. The Report Card provides
an overview of wait times for diagnosis and
treatment of breast cancer in Canada.

source: newswire.ca

Breast-Specific Gamma Imaging (BSGI) Found to Be Highly Sensitive for Early Stage Breast Cancer

NEWPORT NEWS, Va., May 29 /PRNewswire/ -- According to an article in the June issue of Radiology, researchers at The George Washington University Medical Center in Washington, D.C. have shown that Breast-Specific Gamma Imaging (BSGI) is highly sensitive in detecting the presence of cancer. The researchers determined that BSGI was a useful detection tool and that it was as sensitive as MRI for most cancers and perhaps more sensitive for ductal carcinoma in-situ, an early stage of breast cancer.

BSGI, molecular imaging of the breast utilizing a high-resolution, small-field-of-view gamma camera, is an increasingly utilized adjunct imaging modality for the diagnosis of breast cancer. Initial studies with this imaging technique report sensitivities similar to MRI with a higher specificity -- which is the ability of a test to show when disease is not present.

source: PRNewswire

Naviscan PET Systems and Rockville PET Imaging Partner to Bring a New Breast Imaging Technology to New York

SAN DIEGO, May 21 /PRNewswire/ -- Naviscan PET Systems, Inc., a privately held company that manufactures and develops high-resolution PET scanners, announced today the newest installation of the PEM Flex(TM) Solo II scanner at Rockville PET Imaging, P.C. in Rockville Centre, New York. This installation marks the beginning of a multi-unit deal between Naviscan and the operators of Rockville PET Imaging that will bring organ specific, molecular imaging technology to multiple centers throughout the New York state area.

"We are pleased and excited at the growing strategic relationship between Rockville PET Imaging and Naviscan PET Systems," said Paul J. Mirabella, Chairman and CEO of Naviscan. "Both of us believe that this leading-edge technology will significantly and positively influence the effective management of breast cancer patients. Moreover, this multi-unit order represents a highly visible commitment on the part of Rockville PET Imaging to provide differential, personalized healthcare and diagnostic services throughout the greater New York metropolitan area."

source: Yahoo Finance (press release)

MRI Use May Explain Part Of The Trend In Rising Mastectomies Say Mayo Researchers

The number of women undergoing mastectomy (total breast removal) for early-stage breast cancer has increased in the last three years at Mayo Clinic in Rochester. The increase follows a steady decline during the prior seven years.

Researchers say the reasons for this increase are unclear. But they have determined that women at Mayo Clinic who underwent diagnostic magnetic resonance imaging (MRI) prior to surgery to treat early-stage breast cancer had a higher rate of mastectomy, compared to women who did not have an MRI.

source: Medical News Today

Supplemental Breast Ultrasound Boosts Cancer Detection

Among women at high risk of developing breast cancer, breast ultrasound combined with mammography may detect more cancers than mammography alone, according to results of a multicenter trial that included UT Southwestern Medical Center researchers.

Overall, 40 participants were diagnosed with breast cancer. Of those cases, a dozen lesions were suspicious only on ultrasound and eight were suspicious on both ultrasound and mammography.

The most recent findings, presented in the current issue of The Journal of the American Medical Association, are from the first round of screening in the American College of Radiology Imaging Network's ACRIN-6666 trial. More than 2,800 women at high risk of developing breast cancer participated. The median age of the participants was 55 years and more than half had a personal history of breast cancer.

source: Medical News Today

Siemens To Showcase Full Field Digital Mammography System And Other Breast Imaging Innovations At Symposium Mammographicum 2008

At Symposium Mammographicum 2008, in Lille, France, Siemens will be showcasing the latest innovations in full field digital mammography and breast imaging. In addition to the new MAMMOMAT Inspiration, the ACUSON S2000 ultrasound system and the MammoReport workstation will be displayed on stand 11/12.

The MAMMOMAT Inspiration is a full field digital mammography system designed to meet the needs of the patient, the user and clinician. New compression technologies, paddle design and mood lighting offer the latest in patient comfort, plus the isocentric rotation of the X-ray tube and examination functionality have been enhanced to offer easy and fast workflow to improve patient throughput. Furthermore, the MAMMOMAT Inspiration is a future proof solution for stereotactic biopsy and to provide 3D imaging using tomosynthesis.

source: MedicalNewsToday

Six-Month Follow-Up Diagnostic Mammograms Recommended for Women with Probably Benign Lesions

Radiologists can, with confidence, recommend a six-month follow-up diagnostic mammogram rather than an immediate biopsy for patients with “probably benign” breast lesions, a new study emphasizes.

The study found that six-month short-interval follow-up examinations had an 83% sensitivity, which is similar to the sensitivity of other diagnostic mammograms, said Erin J. Aiello Bowles, MPH, lead author of the study from the Group Health Center for Health Studies. High sensitivity means identifying a high proportion of “true positives” (actual cancer cases) and a low proportion of “false negatives” (cases mistakenly deemed benign).

source: American Roentgen Ray Society

Alternative To Biopsy For Women With Probably Benign Lesions

Radiologists can, with confidence, recommend a six-month follow-up diagnostic mammogram rather than an immediate biopsy for patients with "probably benign" breast lesions, a new study emphasizes.

The study found that six-month short-interval follow-up examinations had an 83% sensitivity, which is similar to the sensitivity of other diagnostic mammograms, said Erin J. Aiello Bowles, MPH, lead author of the study from the Group Health Center for Health Studies. High sensitivity means identifying a high proportion of "true positives" (actual cancer cases) and a low proportion of "false negatives" (cases mistakenly deemed benign).

source: Medical News Today

DR Systems’ Integration of Mammography with PACS to Be Showcased at ACR Meeting

SAN DIEGO--(BUSINESS WIRE)--DR Systems will be demonstrating its industry-leading approach to integrating digital mammography into its top-ranked Unity™ RIS/PACS at the American College of Radiology’s 33rd National Conference on Breast Cancer.

The conference will be held May 8-10 in Orlando, Fla. DR Systems will be at Booth 103 in the Coquita Exhibit Hall.

Nearly 50 facilities nationwide have adopted, or are in the process of adopting, DR Systems’ sophisticated integration of PACS and digital mammography.

DR Systems avoids the problems of reading and archiving digital mammograms on a stand-alone mammography workstation by tightly integrating digital mammograms with its PACS. This approach saves capital costs and floor space in the radiology department and better leverages the institution’s investment in its PACS. It also makes radiologists more efficient and productive.

sourc: BusinessWire

Sectra: Women in Brussels Provided Choice of Mammography with Unmatched Lowest Radiation Dose

Brussels Menopause Center, a private clinic for women’s health in Belgium, has chosen Sectra MicroDose Mammography to offer women in Brussels mammography examinations at the lowest radiation dose on the market. The clinic is first in the Brussels region to offer women this benefit.

Brussels Menopause Center is a highly specialized women’s health clinic. Specialties include gynecology, mammography, and detection and treatment of osteoporosis. The clinic performs approximately 7,000 screening and clinical mammography examinations annually.

The clinic is digitizing its mammography operations and will implement Sectra’s total solution for digital mammography, including Sectra MicroDose Mammography and Sectra Breast Imaging PACS (a system for managing and archiving digital breast images). With Sectra’s solution, Brussels Menopause Center will be able to offer women in Brussels mammography examinations with a significantly lower radiation dose than any other system on the market. Digitizing the mammography operations will also increase workflow efficiency and provide radiologists with instant access to images and information regardless of location.

source: Business Wire

Carestream Health Announces Canadian Orders for its Mammograpgy System

ROCHESTER, N.Y. - Carestream Health, Inc., has signed contracts for its computed radiography-based mammography solutions with healthcare providers in Canada. The KODAK DIRECTVIEW CR Mammography feature is available for order with new or existing CR 850/950/975 systems and the recently announced Classic and Elite CR systems. These flexible CR platforms can be used for both mammography and general radiography exams.

The following mammography providers are among those that have placed orders for the CR Mammography feature:
Courtice Medical Center (Courtice, Ontario) purchased a KODAK DIRECTVIEW CR 850 with the CR Mammography feature as a dedicated mammography unit.

Insight Medical Imaging (Spruce Grove, Alberta) purchased two KODAK DIRECTVIEW Elite CR Systems with the CR Mammography feature.

full press release at Carestream

Should we be concerned about mammography utilization in the Medicare population?

The May issue of the Journal of the American College of Radiology (JACR) examines current trends in mammography utilization in the Medicare population - specifically, how digital mammography may be affecting the rate of women being screened for breast cancer, as well as validating data from recent reports that a decline in the overall screening rate for women over age 40 exists.

Recent Trends in Mammography Utilization in the Medicare Population: Is There a Cause for Concern? is authored by Vijay M. Rao, M.D., David C. Levin, M.D., Laurence Parker, Ph.D., and Andrea J. Frangos, M.S., and uses data from the Centers for Medicare & Medicaid Services - which supplies insight into utilization, types of examinations, and providers of services - rather than only survey data, which does not distinguish a difference between screening and diagnostic mammography, from which to draw conclusions.

source: Medicexchange, UK

St John's Hospital Receives First MAMMOMAT Inspiration In The UK

St John's Hospital in Livingston, part of NHS Lothian's University Hospitals Division, has installed the first Siemens new generation full-field digital mammography system in the UK.

Part of the 9 system order via the Scottish Procurement Framework, the MAMMOMAT Inspiration was recently designed with the input of healthcare professionals to create an easy-to-operate and patient-friendly system. Offering quick exposure and display times, the MAMMOMAT Inspiration speeds up patient throughput and provides detailed digital images for diagnosis.

The St John's Hospital installation has replaced an old analogue system, meaning that examination times are now shorter and deliver improved departmental efficiency. The introduction of a digital system has also eliminated the need for processing chemistry and traditional X-ray film.

source: MedicalNewsToday

Mammograms Benefit Women Into Their 70s

New research from The Netherlands suggests that mammograms benefit women up to the age of 75 by cutting deaths; the researchers claim this is the first study to show this because until the late 1990s, few women over 70 were undergoing mammogram screening.

The study is the work of Jacques Fracheboud, a senior researcher at the Erasmus Medical Center in Rotterdam, and colleagues, who presented their findings at the 6th European Breast Cancer Conference (EBCC-6) in Berlin, on Friday 18th of April.

In many countries, breast screening programmes stop at the age of 70. However, in 1998 The Netherlands extended the cut off age to 75.

source: MedicalNewsToday

Use Of Screening Breast MRIs Endorsed For Some Women

The American Society of Breast Disease's Consensus Committee confirms that based on the most current data available, screening MRI is appropriate as an adjunct to mammography, clinical breast examination, and ultrasonography for breast cancer detection in women at high risk of breast cancer.

The Committee concurred with recently revised guidelines issued by the American Cancer Society that recommend annual MRI screening based on evidence to include: BRCA mutation, first-degree relatives of BRCA carriers who are untested, and women with a lifetime risk ~20-20% or greater as defined by BRCAPRO or other models that are largely dependent on family history.

source: MedicalNewsToday

MRI before surgery leads to better-adapted treatment for breast cancer

Berlin, Germany: The early use of magnetic resonance imaging (MRI) in women diagnosed with breast cancer can often lead to a better adapted surgical approach to the tumour, a scientist told the 6th European Breast Cancer Conference (EBCC-6) today (Wednesday April 16). Dr. David Martinez-Cecilia, a surgeon from the General Surgery Service, directed by Prof. Rufian-Peña, in the Hospital Universitario Reina Sofia, Cordoba, Spain, said that this technique should become standard in determining the stage of the tumour before any operation.

Dr. Martinez-Cecilia and his team studied 249 patients who were undergoing surgery for breast cancer, and carried out routine MRI as soon as a biopsy showed malignancy. If additional lesions were discovered, a further biopsy was carried out on them.

“Using MRI, we found 20 additional malignant lesions in 18 patients”, he said, “and that meant that for 15 patients we were able to change the surgical treatment to one which took care of all the tumours, as opposed to the single one that had originally been diagnosed.”

source: European CanCer Organization Press Release

MAMMOMAT Inspiration Designed To Optimise Breast Screening Procedures Via Smoother Workflow And Increased Patient Comfort

The first Full-Field Direct Digital Mammography system from Siemens has been unveiled. The MAMMOMAT Inspiration has been developed from the input and inspiration of healthcare professionals to combine speed, superior image quality and examination comfort.

The new system is fresh in design to meet the needs of the patient, the user and clinician. New compression technologies, paddle design and mood lighting offer the latest in patient comfort; the isocentric rotation of the X-ray tube and examination functionality have been enhanced to offer easy and fast workflow to improve patient throughput and image resolution of the whole breast is advanced for detailed diagnosis.

source: MedicalNewsToday

Report from ARRS: Telemammography over Internet proves feasible, cost-effective

By: H. A. Abella

Nearly 30,000 cases and three years of experience have confirmed that the transmission and interpretation of digital mammography exams to and from a remote location through commercially available high-speed cable Internet is feasible, safe, reliable, and cost-effective, according to a Columbia University study.

"There haven't been any glitches since we began, but we have made long-distance transmission better and faster," said principal investigator Dr. Alan R. Melton, an assistant professor of radiology at Columbia. "We are refining the system, establishing online dictation, increasing transmission speeds, increasing the efficiency of the routing, and diminishing downtime."

source: Diagnostic Imaging

New York Times Examines Radiologists' Transition To Digital Mammograms

An increasing number of women undergoing breast cancer screenings are being recalled for additional testing as radiologists are learning to interpret new digital mammograms after switching from traditional X-ray tests, the New York Times reports. According to the Times, 32% of mammography clinics have at least one digital machine, compared with 10% of mammography clinics two years ago.

Some radiologists have said that digital mammograms allow the magnifier contrast and magnification to potentially "see things that were blurry or maybe even invisible" in traditional X-rays, but they add that "it takes time to learn the ropes" of the new technology.

source: Medical News Today

A Diagnosis of Triple-Negative Breast Cancer Doesn’t Always Mean Cancer Spread

Triple-negative breast cancers are a heterogeneous group and may not always be associated with lymph node spread, a new study shows.

The study of 145 triple negative breast cancers (i.e, cancer which is estrogen receptor-negative, progesterone receptor-negative and HER2-negative) in 128 women found that about 23% were moderate or low-grade lesions, said Cecilia Mercado, MD, of New York University School of Medicine, and an author of the study.

Triple negative breast cancer is found in about 15% of breast cancer patients and the patients are usually younger.

The study found that 11 of the 145 cancers had a low histologic grade. Only one of these patients had evidence that their cancer had spread into their lymph nodes. Twenty-three cancers were moderate grade lesions; only five of these 23 had spread into the lymph nodes. That compares to 37 of 111 cancers with a high histologic grade which had lymph node metastases, Dr. Mercado said.

source: ARRS Press Release

MRI Changes Breast Cancer Treatment Choice; Increases Time To Treatment

More than a quarter of breast cancer patients who had an MRI examination before their initial surgical treatment had their treatment change, according to a study out of Yale University School of Medicine.

The study included 110 who had an MRI examination before treatment and 374 who did not undergo an MRI examination. "MRI prompted biopsy of 70 sites in 44 patients, said Carol Lee, MD, an author of the study, now at Memorial Sloan Kettering Cancer Center in NY. Sixteen additional sites of cancer were found in 13 (12%) women, she said.

Surgical treatment was changed in 31 (28%) cases, she added. Fifteen patients had mastectomy rather than lumpectomy. Six had more extensive lumpectomy and three had treatment for cancer that was detected in the opposite breast.

source:American Roentgen Ray Society

Elderly Benefit From Screening Mammography

Although guidelines keep changing regarding screening mammography in elderly patients, those older than 70 years old continue to benefit from this exam, showing that with frequent mammograms breast cancers can be found sooner, according to a recent study conducted by researchers at Jacobi Medical Center and Albert Einstein College of Medicine, in Bronx, NY.

“Our initial interest was sparked by the changing mammographic guidelines in the elderly age group and the differences in the guidelines between organizations including the American Cancer Society and American College of Radiology,” said Jason Salsamendi, MD, lead author of the study. “We also noticed that we were performing a significant number of screening mammograms in elderly patients at our institution and became curious about the incidence of occult breast cancer in this age group,” he said.

source: RedOrbit

In Shift to Digital, More Repeat Mammograms

DENISE GRADY

It is a phone call that women dread. Something is not quite right on the mammogram: come back for another one. But don’t worry, the script goes, most repeat tests wind up normal.

Still, most women know someone who has breast cancer, and even the calmest, most rational minds may think the worst when summoned back to the clinic.

At many centers, these nerve-racking calls are on the rise, at least temporarily — the price of progress as more and more radiologists switch from traditional X-ray film to digital mammograms, in which the X-ray images are displayed on a computer monitor.

source article: Blue Ridge Now

Connect Imaging introduces software for Fuji digital mammography systems

Connect Imaging, Inc., a provider of tailor-made PACS (picture archiving and communication systems), has introduced new software for use with FCRm digital mammography systems from FUJIFILM Medical Systems USA.

According to Philip J. Manly, chief executive officer of Connect Imaging, the company developed its newest module, called VCM Port, to address an issue Connect Imaging identified while validating its PACS for use with Fuji’s computed radiography mammography systems installed at one of Connect’s clients.

“We are pleased to offer this software product to other users of Fuji’s mammography CR systems,” Manly said. “Connect Imaging excels at addressing the unique workflow issues associated with digital mammography, including those of integrating prior film-based studies. For Fuji, we created customized software for use with its Flash Plus IIPm console unit to ensure that all portions of a mammography study are hung correctly.”

source: ConnectImaging

Quest International Announces They Will be First in US to Exhibit True 12-Bit Grayscale Mammographic Images

IRVINE, Calif., April 3, 2008 /PRNewswire/ -- Quest International, Inc. (Quest) announced they will show true 12-bit, grayscale mammographic images, utilizing an Apple Mac system, OsiriX and the Totoku, ME551i2, medical LCD display, at the upcoming Society for Imaging Informatics in Medicine (SIIM), to be held in Seattle, Washington.

Quest will be demonstrating the imaging breakthrough using the Apple Mac Pro 8-Core workstation with two ME551i2 medical, LCD displays. The ME551i2 is a 21.3-inch, 5 megapixel, DICOM-compliant diagnostic display. The ME551i2 is the only display able to interface with the new 64-bit version of OsiriX, the most advanced open-source PACS workstation DICOM viewer on the market.

source: PR Newswire

iCAD receives FDA Approval for its SecondLook Digital for use with Fuji’s Digital Mammography System

iCAD®, Inc. (Nasdaq: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions, today announced that iCAD’s SecondLook® Digital Computer-Aided Detection system for mammography received approval from the U.S. Food and Drug Administration for sale withFujifilm Computed Radiography for Mammography (FCRm) systems. SecondLook Digitalfor FCRm is the first CAD product approved and available in the U.S. for use with computer radiography (CR).

“The addition of CAD functionality to CR digital mammography takes screening and diagnostic capabilities to an unprecedented level,” said Rachel Brem, M.D., Director of Breast Imaging and Interventional Care at the George Washington University Hospital. “CAD improves upon existing mammography systems by providing an ability to find overlooked cancers, helping the radiologist find cancer earlier and ultimately improve the level of care for every patient.”

source: iCAD

Whole Breast Ultrasound Powered by Medipattern Shown as an Effective Method for Breast Screening in China

The Medipattern Corporation (TSX VENTURE:MKI), an award-winning developer of computer-aided detection (CAD) medical imaging software designed to aid physicians in making better informed biopsy decisions and to permit a higher standard of care for the millions of patients at risk of cancer, is pleased to announce that partner SonoCine Inc. ("SonoCine") successfully demonstrated automated whole breast ultrasound in breast screening applications in China. In direct comparison between a doctor performing breast scans via traditional 2D frozen frame imaging and automated whole breast ultrasound, the whole breast method found more pathology. Medipattern writes the software that powers the SonoCine viewer building 3D images of the breast and supplies its B-CADTM computer aided detection product to the SonoCine product line.

source: MarketWire

GE Healthcare to offer digital mammography reading workshops at Mediconex Conference in Cairo

GE Healthcare, the $17bn healthcare business of General Electric Company (GE), is highlighting the importance of early screening in the diagnosis of breast cancer by offering digital mammography reading workshops for the first time in Egypt.

To be held at the Mediconex Updates on Breast Cancer and Women's Imaging Symposium to be held at the Cairo International Conference Centre on April 7 and 8, 2008.

This training initiative is in line with the global vision of GE Healthcare, which revolves around its 'Early Health' model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. According to the World Health Organization, breast cancer is the second leading cause of cancer deaths in the world.

source: AME Info

Siemens to Market Carestream Health's Mammography Digitizer

MALVERN, Pa., April 2, 2008 – Siemens Healthcare (www.usa.siemens.com/healthcare) has announced the addition of a mammography digitizing system from Carestream Healthcare, Inc., (Rochester, N.Y.) to its Accessory Solutions product portfolio. The digitizer is offered through Siemens to U.S. healthcare providers.

Carestream Health’s specialized digitizer enables mammography facilities to transition to digital imaging by converting prior film-based diagnostic and screening mammograms into a digital imaging format so they can be viewed in conjunction with digital mammography exams on a diagnostic workstation.

“With this high-performance digitizer, our customers can help mammography providers enhance their productivity and achieve the benefits of an all-digital workflow enabled by our digital mammography systems,” said Anders Steiner, vice president, Special Systems, Siemens Healthcare. “Facilities will now be able to transition from their current processes, which require them to retrieve, display, and re-file prior film-based mammography exams.”

source: Siemens Medical

FUJIFILM Enjoys Consecutive Year of Record FCRm Sales

STAMFORD, Conn., April 1, 2008 /PRNewswire via COMTEX/ -- For the second year in a row, FUJIFILM Medical Systems USA, Inc. has achieved record sales of Fuji Computed Radiography for Mammography (FCRm), further demonstrating its leadership in the breast imaging arena. FUJIFILM's ability to reach a milestone of 500 accredited unit sales in the U.S. within 18 months of FDA approval solidifies its status as the dominant worldwide leader in FFDM installations.

Approved for sale in the U.S. by the FDA in 2006, FCRm presents mammography providers with various equipment configuration combinations, from a centrally located multi-plate reader serving several rooms, to a single plate reader installed right in the exam room.

source: Fuji Medical Systems

Automated 3-D Breast Ultrasound Machine

The newest technology in breast imaging - a fully automated 3-D breast ultrasound machine - is now in use at UT Southwestern Medical Center's Southwestern Center for Breast Care, the first site in Dallas and Fort Worth to obtain the equipment.

Breast ultrasound is a noninvasive procedure that uses sound waves to make a picture of the tissues inside the breast. It has traditionally been used following mammography in the targeted evaluation of a possible abnormality found at screening or on physical examination. Because of recently reported studies, breast cancer screening utilizing ultrasound for high-risk women is beginning to gain traction.

source article: AZoOptics

Breast MRI scans 'overly scare'

Lumps detected in women at a high risk of breast cancer using hi-tech MRI scans overwhelmingly turn out to be false alarms, a Dutch study suggests. But while researchers found five out of six scans which suggested a problem were wrong, they were nonetheless very effective at spotting invasive cancers.

And while false-positives caused anxiety, the study did not find women were rashly opting for mastectomies.

The findings were published in the Annals of Oncology.

source: TamilStar.com

iCAD Awarded New CAD Patent For Integrating Information From Multiple Mammography Images

iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today announced that the United States Patent and Trademark Office recently granted the Company U.S. Patent No. 7,333,645. This patent addresses how the Company’s CAD systems can improve cancer detection by applying technology that integrates information from multiple mammography images, including prior exams.

“We are continuously working to enhance our CAD offerings, including the development of technologies that will further improve CAD performance for radiologists,” said Ken Ferry, President and Chief Executive Officer of iCAD. “It is a strategic priority to expand our portfolio of patents that protect our intellectual property and the innovation that powers iCAD products in the detection of cancer, and we are delighted to be granted this new patent.”

source: iCAD

MRI's high false positive rate has little impact on women's choice of preventive mastectomy

Magnetic resonance imaging (MRI) falsely detects breast cancer in five out of every six positive scans according to new research into the use of MRI for women with a high, inherited risk of developing the disease. However, this high rate of false positives does not have a major impact on a woman’s decision whether or not to have a prophylactic mastectomy.

The study, published today (Wednesday 26 March) in the April issue of the cancer journal, Annals of Oncology [1], also showed that MRI was very good at detecting genuine cases of invasive cancers and ductal carcinoma in situ (DCIS), a localised pre-cancer that can develop into invasive breast cancer, although the authors said that improvements in detection were still necessary.

source article: Eurekalert

RadNet Announces Its Entry into Comprehensive Breast Disease Management Services

LOS ANGELES--(BUSINESS WIRE)--RadNet, Inc. (NASDAQ:RDNT - News), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, today reported that it has expanded its service offering in Southern California to provide a comprehensive approach to diagnosing and treating all forms of breast cancer and breast disease. RadNet’s new BreastLink division was formed with the acquisitions of a prominent Southern California Breast Medical Oncology business and a leading breast surgery business.

According to the American Cancer Society, women living in North America have the highest rate of breast cancer in the world. At this time, there are about 2.5 million breast cancer survivors in the United States. Behind skin cancer, breast cancer is the most common cancer among American women in the United States.

Radnet Inc.

Make Your Mammogram a Positive Experience: Author Offers Guidelines and Tips to Change Women's Negative Attitudes Toward Mammograms

HOUSTON, March 20 /PRNewswire/ -- According to the
National Cancer Institute, 1 in 8 women will develop breast
cancer in her lifetime. More than 40,000 women will die of
breast cancer in the United States this year.The disease is
second only to lung cancer as the leading cause of cancer
deaths in American women.

Throughout her career as a mammographer, Carole
Aydell has heard countless excuses for why women refuse
to get mammograms. Her new book,
"BARING YOUR BREAST: Mammograms: A Positive Experience" (published by
AuthorHouse -- http://www.authorhouse.com),
stresses the importance of mammograms for the early
detection and prevention of breast cancer, and provides
women with the tools necessary to make their next
mammogram experience a positive one.

press release: PR Newswire